PetMed Express Inc (PETS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
PetMed Express Inc stock (PETS) is currently trading at $2.33. PetMed Express Inc PS ratio (Price-to-Sales) is 0.26. Analyst consensus price target for PETS is $2.75. WallStSmart rates PETS as Sell.
- PETS PE ratio analysis and historical PE chart
- PETS PS ratio (Price-to-Sales) history and trend
- PETS intrinsic value — DCF, Graham Number, EPV models
- PETS stock price prediction 2025 2026 2027 2028 2029 2030
- PETS fair value vs current price
- PETS insider transactions and insider buying
- Is PETS undervalued or overvalued?
- PetMed Express Inc financial analysis — revenue, earnings, cash flow
- PETS Piotroski F-Score and Altman Z-Score
- PETS analyst price target and Smart Rating
PetMed Express Inc
📊 No data available
Try selecting a different time range
Smart Analysis
PetMed Express Inc (PETS) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
PetMed Express Inc (PETS) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 266.70% year-over-year
Trading at 1.58x book value, attractively priced
Supporting Valuation Data
PetMed Express Inc (PETS) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Revenue declining -21.70%, a shrinking business
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Paying a premium for growth, expensive relative to earnings expansion
Moderate institutional interest at 37.74%
Supporting Valuation Data
PetMed Express Inc (PETS) Detailed Analysis Report
Overall Assessment
This company scores 43/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 3 register as strengths (avg 9.3/10) while 7 fall into concern territory (avg 1.9/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, EPS Growth, Price/Book. Valuation metrics including Price/Sales (0.26), Price/Book (1.58) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 266.70%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including PEG Ratio (2.32) suggest expensive pricing. Growth concerns include Revenue Growth at -21.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -100.60%, Operating Margin at -25.70%, Profit Margin at -34.70%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -100.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -21.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PETS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PETS's Price-to-Sales ratio of 0.26x trades at a deep discount to its historical average of 1.71x (0th percentile). The current valuation is 94% below its historical high of 4.15x set in Jul 2017, and 1% above its historical low of 0.26x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.3x as trailing revenue scaled faster than the stock price.
Compare PETS with Competitors
Top PHARMACEUTICAL RETAILERS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for PetMed Express Inc (PETS) · HEALTHCARE › PHARMACEUTICAL RETAILERS
The Big Picture
PetMed Express Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 187M with 22% decline year-over-year. The company is currently unprofitable, posting a -34.7% profit margin.
Key Findings
Revenue contracted 22% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -34.7% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor PHARMACEUTICAL RETAILERS industry trends, competitive moves, and regulatory changes that could impact PetMed Express Inc.
Bottom Line
PetMed Express Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About PetMed Express Inc(PETS)
NASDAQ
HEALTHCARE
PHARMACEUTICAL RETAILERS
USA
PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.